Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in Plasmodium berghei ANKA-infected CBA mice

NeuroImmunoModulation

Volumn 13, Issue 1, 2006, Pages 28-35

  Libonati, Rosana M F ^a   Cunha, Maristela G ^a   Souza, José M ^b   Santos, Marcos V N ^a   Oliveira, Salma G ^b   Daniel Ribeiro, Claudio T ^b   Carvalho, Leonardo J M ^c   Do Nascimento, José L M ^a,d  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b INSTITUTO EVANDRO CHAGAS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Centro de Ciencias Biologicas   (Brazil)

Author keywords

Cerebral malaria; Dehydroepiandrosterone; Estradiol; Hormones; Nitric oxide synthase

Indexed keywords

ESTRADIOL CIPIONATE; NITRIC OXIDE SYNTHASE; PRASTERONE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SMEAR; BRAIN; BRAIN MALARIA; CASTRATION; COMA; CONTROLLED STUDY; CONVULSION; DYING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FOLLOW UP; IMMUNE RESPONSE; INOCULATION; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PARALYSIS; PARAMETER; PARASITEMIA; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; BRAIN; CAUSALITY; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; IMMUNITY, INNATE; IMMUNITY, NATURAL; MALARIA, CEREBRAL; MICE; MICE, INBRED CBA; NEUROIMMUNOMODULATION; NITRIC OXIDE SYNTHASE TYPE I; ORCHIECTOMY; PARASITEMIA; PLASMODIUM BERGHEI; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746840084     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093271     Document Type: Article

References (52)

1. Grossman CJ: Regulation of the immune system by sex steroids. Endocr Rev 1984;5:435-455.
2. Roberts CW, Walker W, Alexander J: Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 2001;14:476-488.
3. Olsen NJ, Kovacs WJ: Gonadal steroids and immunity. Endocr Rev 2005;17:369-384.
4. Perignon JL, Druilhe P: Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 1994;89:51-53.
5. Baird JK: Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 1995;11:105-111.
6. Baird JK, Pornomo, Basri H, Bangs MJ, Andersen EM, Jones TR, Masbar S, Harjo Suwarno S, Subianto B, Arbani PR: Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. Am J Trop Med Hyg 1993;49:707-719.
7. Kurtis JD, Mtalib R, Onyango, Duffy PE: Human resistance to Plasmodium falciparum increases during puberty and is predicted by dehydroepiandrosterone sulfate levels. Infect Immun 2001;69:123-128.
8. Leenstra T, Kuile FO, Kariuki SK, Nixon CP, Oloo AJ, Kager PA, Kurtis JD: Dehydroepiandrosterone sulfate levels associated with decreased malaria parasite density and increased hemoglobin concentration in pubertal girls from western Kenya. J Infect Dis 2003;188:297-304.
9. Brabin BJ, Johnson PM: Placental malaria and pre-eclampsia through the looking glass backwards? J Reprod Immunol 2005;65:1-15.
10. Martinez-Espinosa FE, Daniel-Ribeiro CT, Alecrim WD: Malaria during pregnancy in a reference center from the Brazilian Amazon: unexpected increase in the frequency of Plasmodium falciparum infections. Mem Inst Oswaldo Cruz 2004;99:19-21.
11. Craig AG: Pregnancy-associated malaria - on the brink? Trends Parasitol 2004;20:201-204.
12. Guyatt HL, Snow RW: Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev 2004;17:760-769.
13. Van Geertruyden JP, Thomas F, Erhart A, D'Alessandro U: The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 2004;71:35-40.
14. Roberts CW, Satoskar A, Alexander J: Sex steroids, pregnancy-associated hormones and immunity to parasite infection. Parasitol Today 1996;12:382-388.
15. Bouyou-Akotet MK, Issifou S, Meye JF, Kombila M, Ngou-Milama E, Luty AJ, Kremsner PG, Mavongou E: Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies. Clin Infect Dis 2004;38:342-347.
16. Freilich D, Ferris S, Wallace M, Leach L, Kallen A, Frincke J, Ahlem C, Hacker M, Nelson D, Herbert J: 16α-Bromoepiandrosterone, a dehydroepiandrosterone (DHEA) analogue, inhibits Plasmodium falciparum and Plasmodium berghei growth. Am J Trop Med Hyg 2000;63:280-283.
17. Ayi K, Giribaldi G, Skorokhod A, Schwarzer E, Prendergast PT, Arese P: 16α-Bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity. Antimicrob Agents Chemother 2002;46:3180-3184.
18. Benten WP, Wunderlich F, Herrmann R, Kuhn-Velten WN: Testosterone-induced compared with oestradiol-induced immunosuppression against Plasmodium chabaudi malaria. J Endocrinol 1993;139:487-494.
19. Wunderlich F, Benten WP, Lieberherr M, Guo Z, Stamm O, Wrehlke C, Sekeris CE, Mossmann H: Testosterone signaling in T cells and macrophages. Steroids 2002;67:535-538.
20. Zhang Z, Chen L, Saito S, Kanagawa O, Sendo F: Possible modulation by male sex hormone of Th1/Th2 function in protection against Plasmodium chabaudi chabaudi AS infection in mice. Exp Parasitol 2000;96:121-129.
21. Wunderlich F, Marinovski P, Benten WP, Schmitt-Wrede HP, Mossmann H: Testosterone and other gonadal factor(s) restrict the efficacy of genes controlling resistance to Plasmodium chabaudi malaria. Parasite Immunol 1991;13:357-367.
22. Mossmann H, Benten WP, Galanos C, Freudenberg M, Kuhn-Velten WN, Reinauer H, Wunderlich F: Dietary testosterone suppresses protective responsiveness to Plasmodium chabaudi malaria. Life Sci 1997;60:839-848.
23. Benten WP, Ulrich P, Kuhn-Velten WN, Vohr HW, Wunderlich F: Testosterone-induced susceptibility to Plasmodium chabaudi malaria: persistence after withdrawal of testosterone. J Endocrinol 1997;153:275-281.
24. Benten WP, Wunderlich F, Mossmann H: Plasmodium chabaudi: estradiol suppresses acquiring, but not once-acquired immunity. Exp Parasitol 1992;75:240-247.
25. Mackintosh CL, Beeson JG, Marsh K: Clinical features and pathogenesis of severe malaria. Trends Parasitol 2004;20:597-603.
26. Clark IA, Alleva LM, Mills AC, Cowden WB: Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 2004;17:509-539.
27. Hunt NH, Grau GE: Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003;24:491-499.
28. Carvalho LJ, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, Ferreira-da-Cruz MF: Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp Parasitol 2000;95:1-7.
29. de Souza JB, Riley EM: Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect 2002;4:291-300.
30. Bredt DS, Snyder SH: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86:9030-9033.
31. Clark IA, Rockett KA, Cowden WB: Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol Today 1991;7:205-207.
32. Clark IA, Alleva LM, Mills AC, Cowden WB: Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 2004;17:509-539.
33. al-Yaman FM, Mokela D, Genton B, Rockett KA, Alpers MP, Clark IA: Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 1996;90:270-273.
34. Weiss G, Thuma PE, Biemba G, Mabeza G, Werner ER, Gordeuk VR: Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J Infect Dis 1998;177:1064-1068.
35. Maneerat Y, Viriyavejakul P, Punpoowong B, Jones M, Wilairatana P, Pongponratn E, Turner GD, Udomsangpetch R: Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology 2000;37:269-277.
36. Clark IA, Rockett KA, Burgner D: Genes, nitric oxide and malaria in African children. Trends Parasitol 2003;19:335-337.
37. Taylor AM, Day NP, Sinh DX, Loc PP, Mai TT, Chau TT, Phu NH, Hien TT, White NJ: Reactive nitrogen intermediates and outcome in severe adult malaria. Trans R Soc Trop Med Hyg 1998;92:170-175.
38. Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanock SJ, Granger DL, Weinberg JB: Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis 1999;180:1994-2002.
39. Dondorp AM, Planche T, de Bel EE, Angus BJ, Chotivanich KT, Silamut K, Romijn JA, Ruangveerayuth R, Hoek FJ, Kager PA, Vreeken J, White NJ: Nitric oxides in plasma, urine, and cerebrospinal fluid in patients with severe falciparum malaria. Am J Trop Med Hyg 1998;59:497-502.
40. Chiwakata CB, Hemmer CJ, Dietrich M: High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. Infect Immun 2000;68:394-399.
41. Pino P, Vouldoukis I, Dugas N, Conti M, Nitcheu J, Traore B, Danis M, Dugas B, Mazier D: Induction of the CD23/nitric oxide pathway in endothelial cells downregulates ICAM-1 expression and decreases cytoadherence of Plasmodium falciparum-infected erythrocytes. Cell Microbiol 2004;6:839-848.
42. Kremsner PG, Nussler A, Neifer S, Chavez MF, Bienzle U, Senaldi G, Grau GE: Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria. Immunology 1993;78:286-290.
43. Asensio VC, Oshima H, Falanga PB: Plasmodium berghei: is nitric oxide involved in the pathogenesis of mouse cerebral malaria? Exp Parasitol 1993;77:111-117.
44. Favre N, Ryffel B, Rudin W: The development of murine cerebral malaria does not require nitric oxide production. Parasitology 1999;118:135-138.
45. Prada J, Muller S, Bienzle U, Kremsner PG: Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether. J Antimicrob Chemother 1996;38: 95-102.
46. Hanum PS, Hayano M, Kojima S: Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int Immunol 2003;15:633-640.
47. Muniz-Junqueira MI, Silva FO, de Paula-Junior FR, Tosta CE: Thalidomide influences the function of macrophages and increases the survival of Plasmodium berghei-infected CBA mice. Acta Trop 2005;94:128-138.
48. Pasquet JPEE, Zou MH, Ulrich V: Peroxynitrite inhibition of nitric oxide synthases. Biochimie 1996;78:785-791.
49. Robinson VK, Sato E, Nelson DK, Cambi SL, Robbins RA, Hoyt JC: Peroxynitrite inhibits inducible (type 2) nitric oxide synthase in murine lung epithelial cells in vitro. Free Radic Biol Med 2001;30:986-991.
50. Chao CC, Anderson WR, Hu S, Gekker G, Martella A, Peterson PK: Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol 1993;67:178-183.
51. Garcia I, Guler R, Vesin D, Olleros ML, Vassali P, Chvatchko Y, Jacobs M, Ryffel B: Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2. Lab Invest 2000;80:1385-1397.
52. Struik SS, Riley EM: Does malaria suffer from lack of memory? Immunol Rev 2004;201:268-290.